🚨NEW DRUG PRICING REPORT FROM @OversightDems
Our shocking findings confirm what patients have always known: Our system is unfair, unsustainable, and COSTS TAXPAYERS BILLIONS in lost savings.
Now we have Big Pharma's internal docs that show just how bad it is! 👇 1/7
Our shocking findings confirm what patients have always known: Our system is unfair, unsustainable, and COSTS TAXPAYERS BILLIONS in lost savings.
Now we have Big Pharma's internal docs that show just how bad it is! 👇 1/7
Over just a 5 year period, if Medicare had secured the same deals as other federal health care programs that CAN NEGOTIATE, taxpayers would have saved $25.1B on JUST SEVEN DRUGS. 2/7
When we looked at just 3 frequently used insulin products over a 7 year period, we found that Medicare could have saved more than $16.7 BILLION. 3/7
The internal docs we obtained reveal that drug companies relied on Medicare sales to drive revenues and profits. For example: 4/7
And Big Pharma's internal docs show that execs targeted the US for price increases while maintaining or lowering prices in the rest of the world—in large part because of Medicare’s inability to negotiate.
More examples: 5/7
More examples: 5/7
Now, Big Pharma claims that any price reform would come at the expense of innovation, but our previous investigation found that this claim is drastically overblown. The world's top drug companies spent $56B more on stock buybacks and dividends between 2016 & 2020 than on R&D. 6/7
This is life and death for so many people in this country. WE NEED REFORM THAT EMPOWERS MEDICARE TO NEGOTIATE DIRECTLY w/ BIG PHARMA.
We need the #BuildBackBetterAct.
We need the #BuildBackBetterAct.
• • •
Missing some Tweet in this thread? You can try to
force a refresh
